Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers.

Eno CC1, Barton SK2, Dorrani N1, Cederbaum SD1, Deignan JL1, Grody WW1.

Author information

1: University of California, Los Angeles Los Angeles, CA, USA.
2: Washington University, St. Louis, MO, USA.

Abstract

BACKGROUND:

Clinical care teams providing presymptomatic genetic testing often employ advanced confidentiality practices for documentation and result storage. However, patient requests for increased confidentiality may be in conflict with the legal obligations of medical providers to document patient care activities in the electronic health record (EHR). Huntington disease presents a representative case study for investigating the ways centers currently balance the requirements of EHRs with the privacy demands of patients seeking presymptomatic genetic testing.

METHODS:

We surveyed 23 HD centers (53% response rate) regarding their use of the EHR for presymptomatic HD testing.

RESULTS:

Our survey revealed that clinical care teams and laboratories have each developed their own practices, which are cumbersome and often include EHR avoidance. We found that a majority of HD care teams record appointments in the EHR (91%), often using vague notes. Approximately half of the care teams (52%) keep presymptomatic results of out of the EHR.

CONCLUSION:

As genetic knowledge grows, linking more genes to late-onset conditions, institutions will benefit from having professional recommendations to guide development of policies for EHR documentation of presymptomatic genetic results. Policies must be sensitive to the ethical differences and patient demands for presymptomatic genetic testing compared to those undergoing confirmatory genetic testing.